How does 6078's PE Ratio compare to its peers?

6078 is good value based on its Price-To-Earnings Ratio (13.7x) compared to the peer average (18.9x).

How does 6078's PE Ratio compare vs other companies in the HK Healthcare Industry?

6078 is expensive based on its Price-To-Earnings Ratio (13.7x) compared to the Hong Kong Healthcare industry average (13x).

What is 6078's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

6078 is good value based on its Price-To-Earnings Ratio (13.7x) compared to the estimated Fair Price-To-Earnings Ratio (19.4x).

What is the Fair Price of 6078 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

6078 (HK$17.7) is trading below our estimate of [[fair value]] (HK$74.68)

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Hygeia Healthcare Holdings (SZSC:6078) - Stock Price, News & Analysis

6078 Stock Overview

Offers oncology healthcare services in the People's Republic of China.

About the company

6078 fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	4/6
Past Performance	3/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 76.3% below our estimate of its fair value

Earnings are forecast to grow 22.05% per year

Earnings grew by 25% over the past year

Risk Analysis

No risks detected for 6078 from our risk checks.

Hygeia Healthcare Holdings Co., Limited Competitors

China Resources Medical Holdings

SEHK:1515

HK$5.3b

C-MER Medical Holdings

SEHK:3309

HK$2.9b

Chaoju Eye Care Holdings

SEHK:2219

HK$2.0b

Rici Healthcare Holdings

SEHK:1526

HK$1.9b

Price History & Performance

Summary of all time highs, changes and price drops for Hygeia Healthcare Holdings
Historical stock prices
Current Share Price	HK$17.70
52 Week High	HK$51.75
52 Week Low	HK$14.60
Beta	0.23
11 Month Change	-28.48%
3 Month Change	-20.81%
1 Year Change	-65.12%
33 Year Change	-71.68%
5 Year Change	n/a
Change since IPO	-62.93%

Recent updates

Shareholder Returns

	6078	HK Healthcare	HK Market
7D	-2.9%	-1.5%	-1.0%
1Y	-65.1%	-23.5%	15.0%

Return vs Industry: 6078 underperformed the Hong Kong Healthcare industry which returned -23.5% over the past year.

Return vs Market: 6078 underperformed the Hong Kong Market which returned 15% over the past year.

Price Volatility

Is 6078's price volatile compared to industry and market?
6078 volatility
6078 Average Weekly Movement	12.3%
Healthcare Industry Average Movement	8.4%
Market Average Movement	9.0%
10% most volatile stocks in HK Market	19.0%
10% least volatile stocks in HK Market	4.3%

Stable Share Price: 6078 has not had significant price volatility in the past 3 months compared to the Hong Kong market.

Volatility Over Time: 6078's weekly volatility (12%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2009	8,368	Yiwen Zhu	www.hygeia-group.com.cn

Hygeia Healthcare Holdings Co., Limited offers oncology healthcare services in the People's Republic of China. The company owns and operates private for-profit hospitals that offers oncology healthcare services, such as radiotherapy, chemotherapy, surgery, and targeted therapy, as well as cancer diagnosis, treatment, and rehabilitation. It also provides radiotherapy services to third-party hospitals, including radiotherapy center consulting services, licensing of radiotherapy equipment for use in the radiotherapy centers, and maintenance and technical support services for radiotherapy equipment.

Hygeia Healthcare Holdings Co., Limited Fundamentals Summary

How do Hygeia Healthcare Holdings's earnings and revenue compare to its market cap?
6078 fundamental statistics
Market cap	HK$11.03b
Earnings (TTM)	HK$803.76m
Revenue (TTM)	HK$5.15b

13.7x

P/E Ratio

2.1x

P/S Ratio

Is 6078 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6078 income statement (TTM)
Revenue	CN¥4.70b
Cost of Revenue	CN¥3.25b
Gross Profit	CN¥1.44b
Other Expenses	CN¥711.14m
Earnings	CN¥733.36m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	1.18
Gross Margin	30.74%
Net Profit Margin	15.61%
Debt/Equity Ratio	41.1%

How did 6078 perform over the long term?

See historical performance and comparison

6078 Stock Overview

Rewards

Risk Analysis

Hygeia Healthcare Holdings Co., Limited Competitors

SEHK:1515

HK$5.3b

SEHK:3309

HK$2.9b

SEHK:2219

HK$2.0b

SEHK:1526

HK$1.9b

Price History & Performance

Recent News & Updates

Investor sentiment improves as stock rises 34%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

First half 2024 earnings released: EPS: CN¥0.61 (vs CN¥0.53 in 1H 2023)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Recent updates

Investor sentiment improves as stock rises 34%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

First half 2024 earnings released: EPS: CN¥0.61 (vs CN¥0.53 in 1H 2023)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Chairman & Co-CEO recently bought HK$13m worth of stock

Investor sentiment improves as stock rises 21%

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Investor sentiment deteriorates as stock falls 24%

Chairman & Co-CEO recently bought HK$9.0m worth of stock

First half 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 1H 2022)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2023 Results on Aug 29, 2023

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into the acquisition agreement to acquire Datang International (Hong Kong) Limited for CNY 1.2 billion.

Now 22% undervalued after recent price drop

Upcoming dividend of CN¥0.15 per share at 0.4% yield

Full year 2022 earnings released: EPS: CN¥0.77 (vs CN¥0.71 in FY 2021)

Hygeia Healthcare Holdings Co., Limited has completed a Follow-on Equity Offering in the amount of HKD 791.8 million.

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Now 22% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) acquired 30% of KAIYUAN JIEHUA HOSPITAL CO., LTD for CNY 15.3 million.

First half 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.32 in 1H 2021)

Hygeia Healthcare Holdings Co., Limited Omits Dividend for the Six Months Ended June 30, 2022

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2022 Results on Aug 31, 2022

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited Announces Management Changes

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Hygeia Healthcare Holdings Co., Limited Resolves Not to Declare Final Dividend for the Year Ended December 31, 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Chairman & Co-CEO recently bought HK$15m worth of stock

Joint Company Secretary recently bought HK$11m worth of stock

Investor sentiment deteriorated over the past week

Chairman & Co-CEO recently bought HK$4.4m worth of stock

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

Board Member recently sold HK$6.2m worth of stock

Director of Research & Development recently sold HK$2.7m worth of stock

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into a share purchase agreement to acquire 98% stake in Suzhou Yongding Hospital from Ascendent Capital Partners I, L.P. managed by Ascendent Capital Partners (Asia) Limited for CNY 1.7 billion.

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2020 Results on Mar 29, 2021

New 90-day low: HK$45.50

Hygeia Healthcare Holdings Co., Limited Announces Change of Joint Company Secretary